1. Medtech Insight
  2. >>Policy & Regulation
  3. >>Regulation

Contaminated Gas Risk Leads To Worldwide Ventilator Recall

 
• By Brian Bossetta

German medical technology firm Drägerwerk announced a worldwide recall in August of its Drager brand ventilators after tests revealed potential contamination of the gas used with the devices.

RECALL
• Source: Shutterstock

Drägerwerk AG & Co. KGaA has initiated a recall of its Dräger Carina Sub-Acute Care Ventilators to address potential contamination of the breathing gas with 1,3- Dichloropropan-2-ol, a biochemical constituent of the device’s sound insulating polyether polyurethane (PE-PUR) foam.

Drägerwerk subjected devices of different ages to biocompatibility tests to determine the long-term stability of the PE-PUR foam, the US...

Welcome to Medtech Insight

Create an account to read this article

Already a subscriber?

More from Regulation

FDA Document Request Denied As Case Against SurModics Merger Intensifies

 
• By Elizabeth Orr

A federal court in Illinois ruled against SurModics and BC Holdings' request for FDA documents to support a proposed merger. The FTC has challenged the merger, claiming it threatens competition in hydrophilic device coatings. The ruling may indicate the FTC is likely to succeed.

EU Authorities Unite In Call For Urgent Overhaul Of Medtech Regulations

 
• By Amanda Maxwell

EU member states have issued a consensus statement on the urgent need to build momentum to tackle governance and centralization issues as part of much-needed reform of the EU medtech regulatory system.

Whoops! FDA Says Company Marketed Unauthorized Device. The Company Says The FDA Is Wrong

 
• By Brian Bossetta

A recent FDA warning letter claims a Boston firm that specializes in wearable technology marketed a blood pressure device without agency approval. The company rejects the assertion and says the agency is out of step with federal law.

With CMS Coverage Established, Medtronic Looks To Next Steps For Renal Denervation

 
• By Elizabeth Orr

US Medicare has proposed national coverage of renal denervation for patients with uncontrolled hypertension. The treatment is seeing other advances as well, with Medtronic piloting a longer catheter and a multi-organ approach and a blood test to identify the best candidates fresh on the

More from Policy & Regulation

Experts Call For Database Of Medical Device Labels

 
• By Elizabeth Orr

A recent JAMA column called for the US FDA to create an online database of medical device labeling, arguing that the move would increase transparency and help researchers, among other benefits. Medtech Insight discussed the idea with the paper’s lead author.

EU Authorities Unite In Call For Urgent Overhaul Of Medtech Regulations

 
• By Amanda Maxwell

EU member states have issued a consensus statement on the urgent need to build momentum to tackle governance and centralization issues as part of much-needed reform of the EU medtech regulatory system.

Whoops! FDA Says Company Marketed Unauthorized Device. The Company Says The FDA Is Wrong

 
• By Brian Bossetta

A recent FDA warning letter claims a Boston firm that specializes in wearable technology marketed a blood pressure device without agency approval. The company rejects the assertion and says the agency is out of step with federal law.